Mark Sullivan
Doctor
Department of Marketing
NeoClone
United States of America
Biography
Dr. Sullivan is the Director of Phage Technologies at NeoClone. He has years of experience manipulating immunoglobulin molecules to develop novel reagents using phage antibody technology. Dr. Sullivan is an expert in the creation of scFv libraries using novel strategies that eliminate common problems associated with production and use of complex Ab libraries. Mark has worked at the University of Rochester, Johnson & Johnson and Eastman Kodak. He received his PhD from the University of Wisconsin-Madison and his BS from Purdue University.
Research Interest
Business and Management
